Bending the curve: maximising impact with focused HIV prevention

Affiliations

¹ International Clinical Research Center, Departments of Global Health and Medicine, University of Washington, Seattle, WA 98104, USA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: rbarnaba@uw.edu.
² International Clinical Research Center, Departments of Global Health and Medicine, University of Washington, Seattle, WA 98104, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.

Comment

Ruanne V Barnabas et al. Lancet. 2014.

. 2014 Jul 19;384(9939):216-7.

doi: 10.1016/S0140-6736(14)61182-X.

¹ International Clinical Research Center, Departments of Global Health and Medicine, University of Washington, Seattle, WA 98104, USA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: rbarnaba@uw.edu.
² International Clinical Research Center, Departments of Global Health and Medicine, University of Washington, Seattle, WA 98104, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.

No abstract available

Comment on

Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study.
Anderson SJ, Cherutich P, Kilonzo N, Cremin I, Fecht D, Kimanga D, Harper M, Masha RL, Ngongo PB, Maina W, Dybul M, Hallett TB. Anderson SJ, et al. Lancet. 2014 Jul 19;384(9939):249-56. doi: 10.1016/S0140-6736(14)61053-9. Lancet. 2014. PMID: 25042235